Orientador: Marcone Lima Sobreira / Resumo: Introdução: A Síndrome de Klippel Trenaunay (SKT) é uma anomalia vascular caracterizada por ser uma doença rara, com prevalência estimada em 1 caso para cada 100.000 pessoas, diagnosticada clinicamente pela presença de pelo menos dois dos seguintes achados: malformação capilar, malformações venosas e hipertrofia dos tecidos afetados. A literatura científica respalda o manejo dos sintomas e tratamento das veias varicosas em alguns casos selecionados. A melhor abordagem terapêutica é crucial para esses pacientes, tornando-se necessário o melhor conhecimento da história natural da doença, o que justifica o estudo do perfil genético desses pacientes, visto que alguns autores revelaram o papel crucial dos microRNAs na regulação da angiogênese, que parece ser o ponto-chave da SKT. Objetivos: Determinar o perfil global de expressão de miRNA’s em pacientes com SKT em comparação com amostras de sangue de pessoas saudáveis, sem a síndrome. Métodos: A amostra foi constituída por pacientes adultos (> 18 anos) com diagnóstico clínico de SKT, acompanhados no Ambulatório de Malformações Vasculares do Serviço de Cirurgia Vascular e Endovascular do Hospital das Clínicas de Botucatu da Faculdade de Medicina de Botucatu/ UNESP. Como referência, foram utilizadas amostras de sangue de adultos saudáveis (> 18anos), doadores de sangue do Hemocentro da Faculdade de Medicina de Botucatu/ UNESP Botucatu. Resultados: Entre os pacientes com SKT, foram encontrados 3 miRNA com expressão diminuída em compa... (Resumo completo, clicar acesso eletrônico abaixo) / Abstract: Introduction: Klippel Trenaunay Syndrome (KTS) is a vascular malformation characterized by being a rare disease, with a prevalence estimated in 1 case per 100,000 people, diagnosed clinically by the presence of at least two of the following findings: capillary malformation, venous malformations, and hypertrophy of affected tissues. The scientific literature supports the management of symptoms, treatment of varicose veins in selected cases and, rarely, amputations. The best therapeutic approach is crucial for these patients, making it necessary to have a better knowledge of the natural history of the disease, which justifies the study of the genetic profile of these patients, since some authors have revealed the crucial role of microRNAs in the regulation of angiogenesis, which seems to be the key point of KTS. Objectives: To determine the overall expression profile of miRNA’s in patients with KTS compared to blood samples from healthy people without the syndrome. Methods: The sample consisted of adult patients (> 18 years) with clinical diagnosis of KTS, followed at the Vascular Malformation Outpatient Service of the Vascular and Endovascular Surgery Service of Botucatu Medical School, Botucatu Medical School / UNESP. Blood samples from healthy adults (> 18 years old), blood donors from the Botucatu Medical School / UNESP Botucatu Blood Center were used as reference. Results: Among the patients with SKT, 3 miRNA’s with decreased expression were found compared to subjects with... (Complete abstract click electronic access below) / Doutor

RIPPLY2 is an essential part of the formation of somite patterning during embryogenesis and in establishment of rostro-caudal polarity. Here, we describe three individuals from two families with compound-heterozygous variants in RIPPLY2 (NM_001009994.2): c.238A > T, p.(Arg80*) and c.240-4 T > G, p.(?), in two 15 and 20-year-old sisters, and a homozygous nonsense variant, c.238A > T, p.(Arg80*), in an 8 year old boy. All patients had multiple vertebral body malformations in the cervical and thoracic region, small or absent rib involvement, myelopathies, and common clinical features of SCDO6 including scoliosis, mild facial asymmetry, spinal spasticity and hemivertebrae. The nonsense variant can be classified as likely pathogenic based on the ACMG criteria while the splice variants must be classified as a variant of unknown significance. With this report on two further families, we confirm RIPPLY2 as the gene for SCDO6 and broaden the phenotype by adding myelopathy with or without spinal canal stenosis and spinal spasticity to the symptom spectrum.